Abstract

Can Circulating Tumor DNA be Utilized as a Marker to Guide High-Risk Head and Neck Squamous Cell Patients Treatment?

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call